STAT+: Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricing

How 1 sources are covering this

• STATCenter·12h ago

  STAT+: Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricing

  The pharma industry saw its reputation among patient groups inch up last year, a new survey finds, but concerns remain over access and pricing.

  Read at STAT →